Compare SCVL & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCVL | LAB |
|---|---|---|
| Founded | 1978 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.1M | 488.4M |
| IPO Year | 1993 | 2011 |
| Metric | SCVL | LAB |
|---|---|---|
| Price | $17.93 | $1.29 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 753.1K | ★ 1.5M |
| Earning Date | 11-20-2025 | 02-25-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $1,144,197,000.00 | $169,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.76 | ★ N/A |
| Revenue Growth | N/A | ★ 79.77 |
| 52 Week Low | $15.21 | $0.92 |
| 52 Week High | $32.66 | $2.14 |
| Indicator | SCVL | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 50.77 | 41.08 |
| Support Level | $16.81 | $1.24 |
| Resistance Level | $18.48 | $1.34 |
| Average True Range (ATR) | 0.68 | 0.09 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 47.60 | 10.20 |
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.